Join us   Log in  

THE JOURNAL OF SCHOOL AND UNIVERSITY MEDICINE - Volume 9, Issue 3, July-September 2022

Pages: 20-23
Print Article   Download XML  Download PDF


Author: Madalina Stetca, Cristina Burlacenco, Andreea Ördög, Nicoleta Tohanean

Category: Medical


Covid-19 disruption has led to a dramatic loss of patients infected with SarsCov2 agent. With a well reviewed vulnerability for the respiratory and cardiovascular systems, studies have expressed concern also for the neurological system. Lately, a number of cases regarding manifestations of central nervous- and peripheral nervous system have been reported, raising awarennes of the high prevalence of prolonged neurological symptoms.

Although affecting a smaller number of patients in comparison to central nervous system, the peripheral nervous system disorders have impacted the quality of patients’s life to a great extent. Infection with SarsCov2 has been connected with the development of several disorders like Guillain -Barre syndrome, or affection of cranial nerves with anosmia and disgeusia being the most encountered. Furthermore, exacerbation of symptoms involving already established disorders like CIDP and Miastenia Gravis have also been revealed. Nonetheless, neurological complications following vaccination against SarsCov2 infection can not be omitted.

Keywords: COVID-19 pandemic, peripheral neurological complications




  1. Kalra RS, Dhanjal JK, Meena AS, Kalel VC, Dahiya S, Singh B, Dewanjee S, Kandimalla R. COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications. Front Aging Neurosci. 2021 Jun 3;13:662786.
  2. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708-1720.
  3. Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the Nervous System. Cell. 2020;183(1):16-27.e1
  4. Karuppan, M. K. M., Devadoss, D., Nair, M., Chand, H. S., & Lakshmana, M. K. (2021). SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism. Molecular Neurobiology, 58(6), 2465–2480.
  5. Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings, Guerrero et al. BMC Infectious Diseases (2021) 21:515
  6. Najafloo R, Majidi J, Asghari A, Aleemardani M, Kamrava SK, Simorgh S, Seifalian A, Bagher Z, Seifalian AM. Mechanism of Anosmia Caused by Symptoms of COVID-19 and Emerging Treatments. ACS Chem Neurosci. 2021 Oct 20;12(20):3795-3805
  7. Lozada-Nur F, Chainani-Wu N, Fortuna G, Sroussi H. Dysgeusia in COVID-19: Possible Mechanisms and Implications. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;130(3):344-346.
  8. Tseng CC, Hu LY, Liu ME, Yang AC, Shen CC, Tsai SJ. Bidirectional association between Bell's palsy and anxiety disorders: a nationwide population-based retrospective cohort study. J Affect Disord 2017;215:269–73.
  9. Klaser K, Thompson EJ, Nguyen LH, et alAnxiety and depression symptoms after COVID-19 infection: results from the COVID Symptom Study appJournal of Neurology, Neurosurgery & Psychiatry 2021;92:1254-1258.
  10. Kanou S, Wardeh L, Govindarajan S, Macnay K. Guillain-Barre syndrome (GBS) associated with COVID-19 infection that resolved without treatment in a child. BMJ Case Rep. 2022;15(3):e245455
  11. Dhamne MC, Benny R, Singh R, Pande A, Agarwal P, Wagh S, Oak P, Lakhotia A, Godge Y, Bolegave V, Doshi D, Patidar Y, Venkatachalam A, Pujara B, Borse S, Makhija P, Khadilkar S. Guillian--Barre' Syndrome in Patients with SARS-CoV-2: A Multicentric Study from Maharashtra, India. Ann Indian Acad Neurol. 2021 May-Jun;24(3):339-346.
  12. Kang M, Seok HY. Finger Drop-Dominant Variant of Guillain-Barre Syndrome in a Patient With COVID-19: A Case Report. J Korean Med Sci. 2022 May;37(20):e160.
  13. Maer E, ?te?ca M, Toh?nean N, Van?a O, Perju-Dumbrav? L. Chronic demyelinating polyradiculoneuropathy presented after SARS CoV2 mild infection- a case report. HVM Bioflux 2022;14(2):81-84.
  14. Suri V, Pandey S, Singh J, Jena A. Acute-onset chronic inflammatory demyelinating polyneuropathy after COVID-19 infection and subsequent ChAdOx1 nCoV-19 vaccination. BMJ Case Rep. 2021 Oct 4;14(10):e245816.
  15. Van Looy E, Veenker L, Steyaert A, Leenders J, Malfroid G, De Cauwer H. COVID-19-induced exacerbation of chronic inflammatory demyelinating polyneuropathy. J Neurol. 2021 Sep;268(9):3129-3131
  16. Garg RK, Paliwal VK. Spectrum of neurological complications following COVID-19 vaccination. Neurol Sci. 2022 Jan;43(1):3-40.
  17. Sriwastava S, Sharma K, Khalid SH, Bhansali S, Shrestha AK, Elkhooly M, Srivastava S, Khan E, Jaiswal S, Wen S. COVID-19 Vaccination and Neurological Manifestations: A Review of Case Reports and Case Series. Brain Sci. 2022 Mar 18;12(3):407.